LOS ANGELES, Sept. 8, 2014 /PRNewswire/ — Pacific Shore Holdings, Inc. (PSHR) today announced that its Nature-Cide division has granted Med-X, Inc. the exclusive rights to its proprietary natural insecticides. Med-X, Inc. has recognized through trial testing that several of the Nature-Cide products effectively combat several species of insects commonly found in both indoor and outdoor marijuana cultivation. Pacific Shore Holdings, Inc. has been accelerating the Company’s Nature-Cide service and product divisions, since its California state licensing and initial EPA registration was completed earlier this year. The recent results of marketing and initial product roll-out have convinced Management and the Board of Directors to make a strategic decision to move expeditiously to accelerate product awareness in the medical marijuana arena through Med-X, Inc.
“This agreement addresses the need for immediate focus on the hydroponic and patient care aspects of medical marijuana cultivation, as there is a constant issue with insects like spider mites, white flies and caterpillars, which are currently being combated with poisons on a national basis,” states Pacific Shore Holdings, Inc. founder Matthew Mills.
The Nature-Cide product is a proven all-natural pesticide, insecticide and repellent that is non-toxic to humans, pets, livestock, and plant life. According to the Nature-Cide website, the Company’s products “Range from outdoor Pest Management Services to a travel Bed Bug Spray. If you have problems with insects and are looking for a cost effective, safe alternative to dangerous insecticides, give Nature-Cide a try. We guarantee you won’t be disappointed.”
Pacific Shore continues to remain positioned at the forefront of developments in the green products sector.
SOURCE Pacific Shore Holdings, Inc.